Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.11B |
| 2 |
NVIDIA
NVDA
|
+$2.59B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.58B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$2.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.21B |
| 2 |
Lam Research
LRCX
|
+$976M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$771M |
| 4 |
Warner Bros
WBD
|
+$771M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$710M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.73% |
| 2 | Financials | 9.04% |
| 3 | Consumer Discretionary | 7.38% |
| 4 | Healthcare | 7.28% |
| 5 | Industrials | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.1B
| $10.9M | ﹤0.01% |
373,679
+134,383
| +56% | +$3.93M |
|
|
CWEN.A
3002
DELISTED
Clearway Energy Class A
CWEN.A
| $10.9M | ﹤0.01% |
277,366
+60,479
| +28% | +$2.15M |
|
3003
Ambarella
AMBA
$3.25B
| $10.8M | ﹤0.01% |
209,817
+2,192
| +1% | +$137K |
|
3004
Rayonier
RYN
$6.43B
| $10.8M | ﹤0.01% |
523,453
-70,927
| -12% | -$1.56M |
|
3005
Unitil
UTL
$980M
| $10.8M | ﹤0.01% |
206,487
+59,503
| +40% | +$3.05M |
|
3006
Worthington Steel
WS
$1.75B
| $10.8M | ﹤0.01% |
355,010
+159,238
| +81% | +$6.17M |
|
3007
UroGen Pharma
URGN
$2B
| $10.8M | ﹤0.01% |
598,528
+138,806
| +30% | +$2.78M |
|
3008
Wabash National
WNC
$504M
| $10.7M | ﹤0.01% |
1,245,620
+137,548
| +12% | +$1.37M |
|
3009
Galicia Financial Group
GGAL
$8.29B
| $10.7M | ﹤0.01% |
228,468
+25,612
| +13% | +$1.24M |
|
3010
Shoals Technologies Group
SHLS
$1.49B
| $10.7M | ﹤0.01% |
1,621,792
-362,563
| -18% | -$2.97M |
|
|
MANE
3011
Veradermics Inc
MANE
$4.37B
| $10.7M | ﹤0.01% |
+168,975
| New | +$8.52M |
|
3012
Enerpac Tool Group
EPAC
$1.86B
| $10.7M | ﹤0.01% |
292,571
+16,961
| +6% | +$672K |
|
3013
Invesco CurrencyShares Euro Currency Trust
FXE
$346M
| $10.7M | ﹤0.01% |
100,009
+25,000
| +33% | +$2.7M |
|
3014
Ennis
EBF
$548M
| $10.7M | ﹤0.01% |
498,129
-134,710
| -21% | -$2.72M |
|
3015
Myriad Genetics
MYGN
$507M
| $10.6M | ﹤0.01% |
2,366,092
+205,810
| +10% | +$1.07M |
|
3016
CorVel
CRVL
$3.03B
| $10.6M | ﹤0.01% |
194,707
-293
| -0.2% | -$16.9K |
|
|
GRFS
3017
Grifois
GRFS
$5.58B
| $10.6M | ﹤0.01% |
1,325,965
-117,649
| -8% | -$1.04M |
|
3018
Papa John's
PZZA
$995M
| $10.6M | ﹤0.01% |
327,412
-60,202
| -16% | -$2.09M |
|
3019
Invesco WilderHill Clean Energy ETF
PBW
$407M
| $10.6M | ﹤0.01% |
335,904
-135,895
| -29% | -$4.53M |
|
3020
Gevo
GEVO
$372M
| $10.6M | ﹤0.01% |
3,878,382
+1,018,941
| +36% | +$2.11M |
|
3021
PUT
Blackrock
BLK
$170B
| $10.6M | ﹤0.01% |
11,000
-6,200
| -36% | -$6.52M |
|
3022
RUM Group Inc
RUM
$1.63B
| $10.6M | ﹤0.01% |
2,072,685
+1,256,547
| +154% | +$7.22M |
|
|
FIG
3023
PUT
Figma
FIG
$12.6B
| $10.6M | ﹤0.01% |
+500,000
| New | +$13.7M |
|
3024
Global X Copper Miners ETF NEW
COPX
$7.35B
| $10.6M | ﹤0.01% |
138,427
-90,356
| -39% | -$7.48M |
|
3025
Compass Therapeutics
CMPX
$349M
| $10.6M | ﹤0.01% |
1,995,394
+477,979
| +31% | +$2.76M |
|
Similar funds
Goldman Sachs's Q1 2026 Portfolio in Review
As of Q1 2026, Goldman Sachs held 7,166 positions worth $871B, up 6.8% from $815B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs deployed $86.3B of net new capital in Q1 2026, opening 752 new positions and adding to 3,118 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, an estimated $1.21B trimmed.
- Goldman Sachs's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
- Goldman Sachs added most to Microsoft in Q1 2026, an estimated $4.11B increase.
- Goldman Sachs's biggest Q1 2026 reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, cutting an estimated $1.21B.
- Goldman Sachs fully exited Dayforce in Q1 2026, selling an estimated $441M.
- Goldman Sachs's ten largest holdings make up 20% of its $871B portfolio in Q1 2026.
- Goldman Sachs opened 752 new positions and closed 735 in Q1 2026.
- Goldman Sachs's portfolio value rose 6.8% quarter-over-quarter to $871B.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.